U.S. FDA: Tobacco Product Listings Must Be Regularly Updated, June 30 Marks Key Deadline

Jun.25

The U.S. FDA requires all registered tobacco manufacturers to submit product listing change reports by June 30 and December 31 each year. This includes new product launches, product discontinuations, resumptions of production, and significant changes to product information. Reports can be submitted online through the next-generation Tobacco Registration and Listing Module (TRLM NG) system or by mailing paper forms.

Key Points:

·Mandatory reporting frequency: June 30th and December 31st every year.

·Types of changes to report: new product launch, product discontinued or resumed, significant changes in product information.

Submission method:

·Preferred: Tobacco Registration and Listing Module for the Next Generation (TRLM NG) online system;

·Alternate option: Mail the FDA 3741/3741a form.

Prohibited actions: Do not submit duplicate information that has already been reported.

Target audience: All tobacco product manufacturers registered with the FDA.

On June 24, the U.S. Food and Drug Administration (FDA) stated that registered tobacco product manufacturers must report any changes in their tobacco product lists twice a year (June 30 and December 31) to the FDA.

Any changes made by the manufacturer must be reported.

·Introduced any tobacco products for commercial distribution that were not previously included on the list;

·Ceased production, preparation, blending, or processing of any tobacco products for commercial distribution;

·Resumed production, preparation, blending, or processing of any tobacco products previously listed as discontinued;

·Made significant changes to any previously submitted listing information, such as name, label, consumer information, or advertising changes.

·Information previously submitted to the FDA should not be resubmitted.

Updates can be submitted using the new Tobacco Registration and Listing Module Next Generation (TRLM NG). If applicants are unable to submit online using TRLM NG, they can mail the corresponding registration and listing PDF forms (FDA Form 3741 or FDA Form 3741a) to the Document Control Center at the Center for Tobacco Products (CTP).

For resources related to submitting a product list, please visit the Tobacco Registration and Listing - Next Generation (TRLM NG) information page. Manufacturers can also refer to the Registration and Product Listing page for domestic product owners and operators to learn more.

References:

[1] Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments

[2] Tobacco Registration and Listing Module – Next Generation (TRLM NG) Instructions

[3] Contact CTP

Also Read:

[1] Reynolds Tobacco Company Wins U.S. Supreme Court Support to Challenge FDA Ruling Locally

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.